Skip to main content
Erschienen in: International Urogynecology Journal 4/2013

01.04.2013 | Original Article

Transforming growth factor beta 1 gene expression during vaginal vs cutaneous surgical wound healing in the rabbit

verfasst von: Yoram Abramov, Emmet Hirsch, Vladimir Ilievski, Roger P. Goldberg, Sylvia M. Botros, Peter K. Sand

Erschienen in: International Urogynecology Journal | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Reconstructive pelvic surgery outcome is closely related to the vaginal and pelvic wound healing processes. Transforming growth factor beta 1 (TGF-β1) is a principal mediator of wound repair in dermal tissue. We sought to assess this factor’s expression in vaginal and dermal surgical wound repair in the rabbit.

Methods

We excised bilateral 6-mm full-thickness circular segments from the abdominal skin and vagina in 36 New Zealand White (NZW) nulliparous female rabbits. Animals were sacrificed before, on the day of, and 4, 7, 10, 14, 21, 28, and 35 days after tissue wounding, and their wounds were assessed for surface area and TGF-β1 gene transcription by real-time polymerase chain reaction (PCR).

Results

In both the abdominal skin and vagina, TGF-β1 gene transcription increased immediately after tissue injury, reaching maximal levels on days 4–7, and decreased shortly thereafter, attaining minimal values on day 35. A significant correlation between TGF-β1 expression and the wound’s closure rate was found in both tissues.

Conclusions

TGF-β1 gene transcription significantly correlates with the surgical vaginal and dermal wound closure rate, implying that this factor is involved in the process of wound repair in both tissues.
Literatur
1.
Zurück zum Zitat DeLancey JO (2005) The hidden epidemic of pelvic floor dysfunction: achievable goals for improved prevention and treatment. Am J Obstet Gynecol 192:1488–1495PubMedCrossRef DeLancey JO (2005) The hidden epidemic of pelvic floor dysfunction: achievable goals for improved prevention and treatment. Am J Obstet Gynecol 192:1488–1495PubMedCrossRef
2.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRef Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRef
3.
Zurück zum Zitat Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184:1496–1501PubMedCrossRef Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184:1496–1501PubMedCrossRef
4.
Zurück zum Zitat Clark RA (1993) Basics of cutaneous wound repair. J Dermatol Surg Oncol 19:693–706PubMed Clark RA (1993) Basics of cutaneous wound repair. J Dermatol Surg Oncol 19:693–706PubMed
5.
Zurück zum Zitat Abramov Y, Golden B, Sullivan M, Botros SM, Miller JJ, Alshahrour A, Goldberg RP, Sand PK (2007) Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Repair Regen 15:80–86PubMedCrossRef Abramov Y, Golden B, Sullivan M, Botros SM, Miller JJ, Alshahrour A, Goldberg RP, Sand PK (2007) Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Repair Regen 15:80–86PubMedCrossRef
6.
Zurück zum Zitat Abramov Y, Webb A, Miller JR, Alshahrour A, Botros SM, Goldberg RP, Ameer G, Sand PK (2006) Biomechanical characterization of vaginal versus abdominal surgical wound healing in the rabbit. Am J Obstet Gynecol 194:1472–1477PubMedCrossRef Abramov Y, Webb A, Miller JR, Alshahrour A, Botros SM, Goldberg RP, Ameer G, Sand PK (2006) Biomechanical characterization of vaginal versus abdominal surgical wound healing in the rabbit. Am J Obstet Gynecol 194:1472–1477PubMedCrossRef
7.
Zurück zum Zitat Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111–119PubMedCrossRef Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111–119PubMedCrossRef
8.
Zurück zum Zitat Roberts AB, Sporn MB (1996) Transforming growth factor-beta. In: Clark RAF (ed) The molecular and cellular biology of wound repair, 2nd edn. Plenum, New York, pp 275–308 Roberts AB, Sporn MB (1996) Transforming growth factor-beta. In: Clark RAF (ed) The molecular and cellular biology of wound repair, 2nd edn. Plenum, New York, pp 275–308
9.
Zurück zum Zitat Roberts AB, Sporn MB, Assoian RK et al (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83:4167–4171PubMedCrossRef Roberts AB, Sporn MB, Assoian RK et al (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83:4167–4171PubMedCrossRef
10.
Zurück zum Zitat Yazdany T, Wong K, Bhatia NN (2011) Sacrospinous ligament fixation for pelvic organ prolapse in the era of vaginal mesh kits. Curr Opin Obstet Gynecol 23:391–395PubMed Yazdany T, Wong K, Bhatia NN (2011) Sacrospinous ligament fixation for pelvic organ prolapse in the era of vaginal mesh kits. Curr Opin Obstet Gynecol 23:391–395PubMed
11.
Zurück zum Zitat Withagen MI, Vierhout ME, Hendriks JC, Kluivers KB, Milani AL (2011) Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol 118:629–636PubMedCrossRef Withagen MI, Vierhout ME, Hendriks JC, Kluivers KB, Milani AL (2011) Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol 118:629–636PubMedCrossRef
12.
Zurück zum Zitat Moy LS (1993) Management of acute wounds. Dermatol Clin 11:759–766PubMed Moy LS (1993) Management of acute wounds. Dermatol Clin 11:759–766PubMed
13.
Zurück zum Zitat Hom DB, Maisel RH (1992) Angiogenic growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol 101:349–354PubMed Hom DB, Maisel RH (1992) Angiogenic growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol 101:349–354PubMed
14.
Zurück zum Zitat O’Kane S, Ferguson MW (1997) Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29:63–78PubMedCrossRef O’Kane S, Ferguson MW (1997) Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29:63–78PubMedCrossRef
15.
Zurück zum Zitat Lawrence DA (1991) Identification and activation of latent transforming growth factor beta. Methods Enzymol 198:327–336PubMedCrossRef Lawrence DA (1991) Identification and activation of latent transforming growth factor beta. Methods Enzymol 198:327–336PubMedCrossRef
16.
Zurück zum Zitat Derynck R, Zang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584PubMedCrossRef Derynck R, Zang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584PubMedCrossRef
18.
Zurück zum Zitat McCartney-Francis NL, Wahl SM (1994) Transforming growth factor beta: matter of life and death. J Leukocyte Biol 55:401–409PubMed McCartney-Francis NL, Wahl SM (1994) Transforming growth factor beta: matter of life and death. J Leukocyte Biol 55:401–409PubMed
19.
Zurück zum Zitat Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201–210PubMedCrossRef Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201–210PubMedCrossRef
20.
Zurück zum Zitat Gailit J, Welch MP, Clark RA (1994) TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 103:221–227PubMedCrossRef Gailit J, Welch MP, Clark RA (1994) TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 103:221–227PubMedCrossRef
21.
Zurück zum Zitat Zambruno G, Marchisio PC, Marconi A et al (1995) Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 129:853–865PubMedCrossRef Zambruno G, Marchisio PC, Marconi A et al (1995) Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 129:853–865PubMedCrossRef
22.
Zurück zum Zitat Montesano R, Orci L (1988) Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci U S A 85:4894–4897PubMedCrossRef Montesano R, Orci L (1988) Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci U S A 85:4894–4897PubMedCrossRef
23.
Zurück zum Zitat Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111PubMedCrossRef Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111PubMedCrossRef
24.
Zurück zum Zitat Schmid P, Cox D, Bilbe G et al (1993) TGF-beta s and TGF-beta type II receptor in humans epidermis: differential expression in acute and chronic skin wounds. J Pathol 171:191–197PubMedCrossRef Schmid P, Cox D, Bilbe G et al (1993) TGF-beta s and TGF-beta type II receptor in humans epidermis: differential expression in acute and chronic skin wounds. J Pathol 171:191–197PubMedCrossRef
25.
Zurück zum Zitat Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF (1989) Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A 86:2229–2233PubMedCrossRef Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF (1989) Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A 86:2229–2233PubMedCrossRef
26.
Zurück zum Zitat Salomon GD, Kasid A, Bernstein E, Buresh C, Director E, Norton JA (1990) Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor-beta. Surgery 108:318–322PubMed Salomon GD, Kasid A, Bernstein E, Buresh C, Director E, Norton JA (1990) Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor-beta. Surgery 108:318–322PubMed
27.
Zurück zum Zitat Cosker T, Elsayed S, Gupta S, Mendonca AD, Tayton KJ (2005) Choice of dressing has a major impact on blistering and healing outcomes in orthopaedic patients. J Wound Care 14:27–29PubMed Cosker T, Elsayed S, Gupta S, Mendonca AD, Tayton KJ (2005) Choice of dressing has a major impact on blistering and healing outcomes in orthopaedic patients. J Wound Care 14:27–29PubMed
28.
Zurück zum Zitat Agren MS, Karlsmark T, Hansen JB, Rygaard J (2001) Occlusion versus air exposure on full-thickness biopsy wounds. J Wound Care 10:301–304PubMed Agren MS, Karlsmark T, Hansen JB, Rygaard J (2001) Occlusion versus air exposure on full-thickness biopsy wounds. J Wound Care 10:301–304PubMed
Metadaten
Titel
Transforming growth factor beta 1 gene expression during vaginal vs cutaneous surgical wound healing in the rabbit
verfasst von
Yoram Abramov
Emmet Hirsch
Vladimir Ilievski
Roger P. Goldberg
Sylvia M. Botros
Peter K. Sand
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 4/2013
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1905-x

Weitere Artikel der Ausgabe 4/2013

International Urogynecology Journal 4/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.